MIVI Neuroscience

MIVI Neuroscience is a private, pre-revenue medical device company founded in 2015 and headquartered in Eden Prairie, Minnesota. The company is developing the next generation of neurointerventional devices, with its lead investigational product being the DAISe™ Thrombectomy System, designed as a mechanical backstop to assist in clot retrieval and reduce distal embolization. MIVI's strategy is deeply collaborative, working closely with neurointerventionalists to identify and solve pressing clinical challenges in stroke treatment, particularly for difficult-to-treat distal occlusions. The company is in the development and regulatory phase, with its technology not yet commercially available.

Next-generation mechanical thrombectomy platform focused on improving aspiration in distal vessels and reducing distal embolization via a 'mechanical backstop' design.

The neurothrombectomy market is dominated by large players like Medtronic, Stryker, Johnson & Johnson (Cerenovus), and Penumbra. MIVI must differentiate by proving superior efficacy in reducing distal embolization or improving revascularization in challenging distal occlusions, where current technologies have limitations.